Versant Capital Management, Inc Celcuity Inc. Transaction History
Versant Capital Management, Inc
- $578 Million
- Q1 2025
A detailed history of Versant Capital Management, Inc transactions in Celcuity Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 349 shares of CELC stock, worth $3,751. This represents 0.0% of its overall portfolio holdings.
Number of Shares
349Holding current value
$3,751% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CELC
# of Institutions
103Shares Held
30MCall Options Held
17.5KPut Options Held
100-
Bvf Inc San Francisco, CA3.47MShares$37.3 Million1.7% of portfolio
-
Baker Bros. Advisors LP New York, NY2.68MShares$28.8 Million0.39% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.57MShares$27.6 Million2.34% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$25.4 Million1.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$17.8 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $161M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...